Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
The American Review of Respiratory Disease|June 1, 1977
Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophyllineM Fixley, D D Shen, D L AzarnoffJournal of Pharmaceutical Sciences|July 1, 1978
Theophylline bioavailability following chronic dosing of an elixir and two solid dosage formsD D Shen, M Fixley, D L AzarnoffClinical Pharmacokinetics|May 1, 1983
Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylatesR O Day, D D Shen, D L AzarnoffCancer Treatment Reports|January 1, 1978
Separation and identification of impurities in parenteral methotrexate dosage formsC E Hignite, D D Shen, D L AzarnoffClinical Pharmacokinetics|September 1, 1977
The effects of urine pH and plasma protein binding on the renal clearance of disopyramideJ L Cunningham, D D Shen, I Shudo, et al.Journal of Pharmaceutical Sciences|May 1, 1977
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulationF Bochner, D H Huffman, D D Shen, et al.Biopharmaceutics & Drug Disposition|January 1, 1980
Disposition kinetics of disopyramide in patients with renal insufficiencyD D Shen, J L Cunningham, I Shudo, et al.Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotypeD D Shen, J P Hosler, R L Schroder, et al.Clinical Pharmacokinetics|January 1, 1976
Drug protein binding and the nephrotic syndromeR Gugler, D L AzarnoffThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Diphenylhydantoin potency and plasma protein bindingD W Shoeman, D L AzarnoffPageof 15